Feilong Meng

695 citations
24 papers · 501 indexed · h-index 16
Topics
Mitochondrial Function and Pathology (17 papers)RNA modifications and cancer (12 papers)RNA and protein synthesis mechanisms (12 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Feilong Meng

24 papers receiving 497 citations

Peers

Feilong Meng
Comparison fields: 5 of 55
  • Molecular Biology 462
  • Clinical Biochemistry 80
  • Cancer Research 66
  • Immunology 44
  • Oncology 25
Replace Shinsuke Ninomiya with:
Shinsuke Ninomiya Japan
Mariangela Corricelli Italy
Sakie Katsumura Japan
Kim D. Falkenberg Netherlands
Dana Pearl Canada
Marian León Spain
Javier Prieto Spain
Kevin Berendse Netherlands
Michael Martinez United States
Elodie Dumon France
Feilong Meng relative to Shinsuke Ninomiya Japan Shinsuke Ninomiya's profile →
Citations per field
00.5×8.4×
Shinsuke Ninomiya · 1×
Citations per year

Countries citing papers authored by Feilong Meng

Since Specialization
Citations

This map shows the geographic impact of Feilong Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilong Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilong Meng more than expected).

Fields of papers citing papers by Feilong Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilong Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilong Meng. The network helps show where Feilong Meng may publish in the future.

Co-authorship network of co-authors of Feilong Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Feilong Meng. A scholar is included among the top collaborators of Feilong Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feilong Meng. Feilong Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 28
4 17
5 5
6 13
7 25
8 15
9 21
10 15
11 32
12 9
13 20
14 61
15 16
16 33
17 1
18 58
19 43
20 16

About Feilong Meng

Feilong Meng is a scholar working on Clinical Biochemistry, Molecular Biology and Cancer Research, having authored 24 papers that have together received 501 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (17 papers), RNA modifications and cancer (12 papers) and RNA and protein synthesis mechanisms (12 papers). The work is most often cited by research in Clinical Biochemistry (80 citations), Molecular Biology (462 citations) and Sensory Systems (22 citations). Feilong Meng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Min‐Xin Guan, Meng Wang, Yanchun Ji, Mi Zhou, Yun Xiao, Xiaohui Cang, Jing Zheng, Jun Qin Mo, Shasha Gong and Xiaoli Zhao. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026